PT97785A - Metodo para a tratamento da impotencia utilizando, por exemplo, doxazosina - Google Patents

Metodo para a tratamento da impotencia utilizando, por exemplo, doxazosina

Info

Publication number
PT97785A
PT97785A PT97785A PT9778591A PT97785A PT 97785 A PT97785 A PT 97785A PT 97785 A PT97785 A PT 97785A PT 9778591 A PT9778591 A PT 9778591A PT 97785 A PT97785 A PT 97785A
Authority
PT
Portugal
Prior art keywords
doxazosine
improving treatment
relieving
male
erectile impotence
Prior art date
Application number
PT97785A
Other languages
English (en)
Other versions
PT97785B (pt
Inventor
George Mclean Milne
Michael Grant Wyllie
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of PT97785A publication Critical patent/PT97785A/pt
Publication of PT97785B publication Critical patent/PT97785B/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Harvester Elements (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Electrical Discharge Machining, Electrochemical Machining, And Combined Machining (AREA)
  • Tone Control, Compression And Expansion, Limiting Amplitude (AREA)
  • Surface Acoustic Wave Elements And Circuit Networks Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Saccharide Compounds (AREA)
PT97785A 1990-05-31 1991-05-29 Metodo para a tratamento da impotencia utilizando, por exemplo, doxazosina PT97785B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US53149490A 1990-05-31 1990-05-31

Publications (2)

Publication Number Publication Date
PT97785A true PT97785A (pt) 1992-02-28
PT97785B PT97785B (pt) 1999-01-29

Family

ID=24117862

Family Applications (1)

Application Number Title Priority Date Filing Date
PT97785A PT97785B (pt) 1990-05-31 1991-05-29 Metodo para a tratamento da impotencia utilizando, por exemplo, doxazosina

Country Status (15)

Country Link
EP (1) EP0459666B1 (pt)
JP (1) JP2522609B2 (pt)
KR (1) KR930010582B1 (pt)
AT (1) ATE113839T1 (pt)
AU (1) AU620282B2 (pt)
CA (1) CA2043440C (pt)
DE (1) DE69105040T2 (pt)
DK (1) DK0459666T3 (pt)
HU (1) HU208076B (pt)
IE (1) IE63837B1 (pt)
IL (1) IL98258A (pt)
MY (1) MY106528A (pt)
NZ (1) NZ238339A (pt)
PT (1) PT97785B (pt)
ZA (1) ZA914135B (pt)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4223800A1 (de) * 1992-07-20 1994-01-27 Cassella Farbwerke Mainkur Ag Verwendung von 1.2.5-Oxadiazol-2-oxiden zur Behandlung erektiler Dysfunktionen
EP0611248B1 (en) * 1993-02-10 2000-03-22 B.M.R.A. Corporation B.V. Pharmaceutical composition for treating impotence containing an alpha-1-inhibitor and an alpha-2 inhibitor
US6143746A (en) * 1994-01-21 2000-11-07 Icos Corporation Tetracyclic cyclic GMP-specific phosphodiesterase inhibitors, process of preparation and use
GB9514465D0 (en) * 1995-07-14 1995-09-13 Glaxo Lab Sa Chemical compounds
KR970706823A (ko) 1994-11-16 1997-12-01 멀닉스 캐슬린 피. 디히드로피리미딘과 그 사용법(dihydropyrimidines and uses thereof)
US6268369B1 (en) 1994-11-16 2001-07-31 Synaptic Pharmaceutical Corporation 5-(heterocyclic alkyl)-6-aryl-dihydropyrimidines
EP0814775A1 (en) * 1995-03-14 1998-01-07 Vivus, Inc. Method and kit for preventing erectile dysfunction
GB9514473D0 (en) * 1995-07-14 1995-09-13 Glaxo Lab Sa Chemical compounds
GB9514464D0 (en) 1995-07-14 1995-09-13 Glaxo Lab Sa Medicaments
US6228861B1 (en) 1995-11-16 2001-05-08 Synaptic Pharmaceutical Corporation Dihydropyrimidines and uses thereof
ATE215950T1 (de) * 1996-05-10 2002-04-15 Icos Corp Carbolinderivate
US6245773B1 (en) 1996-05-16 2001-06-12 Synaptic Pharmaceutical Corporation 5-(heterocyclic alkyl)-6-aryl-dihydropyrimidines
US6172066B1 (en) 1996-05-16 2001-01-09 Synaptic Pharmaceutical Corporation Dihydropyrimidines and uses thereof
EP0849265A1 (de) * 1996-12-20 1998-06-24 HEUMANN PHARMA GmbH Neue polymorphe Form von Doxazosin-Mesylat (Form II)
ATE353892T1 (de) * 1996-12-20 2007-03-15 Heumann Pharma Gmbh & Co Neue polymorphe form von doxazosinmesylat (form iii)
EP0849264A1 (de) * 1996-12-20 1998-06-24 HEUMANN PHARMA GmbH Neue polymorphe Form von doxazosinmesylat (Form I)
PL341575A1 (en) * 1997-12-16 2001-04-23 Pfizer Prod Inc Composition effective in treating impotency
DE19800214A1 (de) 1998-01-06 1999-07-15 Knoll Ag Verfahren zur Herstellung von Doxazosin-Mcsylat in einer als Form A bezeichneten Kristallmodifikation und ein Zwischenprodukt dafür
US6268377B1 (en) * 1998-09-28 2001-07-31 Merck & Co., Inc. Method for treating androgen-related conditions
RU2135195C1 (ru) * 1998-12-17 1999-08-27 Овсюк Валерий Григорьевич Способ получения материала, содержащего клетки предстательной железы, материал, содержащий клетки предстательной железы, и способы лечения фиброматоза матки, хронического простатита и нарушений мужской половой функции методом трансплантации
US6274585B1 (en) 1998-12-23 2001-08-14 Synaptic Pharmaceutical Corporation Dihydropyrimidines and uses thereof
US6680323B2 (en) 1998-12-23 2004-01-20 Synaptic Pharmaceutical Corporation Dihydropyrimidines and uses thereof
GB0008332D0 (en) * 2000-04-04 2000-05-24 Pfizer Ltd Treament
US6521647B2 (en) 2000-04-04 2003-02-18 Pfizer Inc. Treatment of renal disorders
AU2001259848B2 (en) * 2000-05-12 2005-10-13 Septodont Holding Sas Local anesthetic methods and kits
US6720324B2 (en) 2000-07-05 2004-04-13 Synaptic Pharmaceutical Corporation Selective melanin concentrating hormone-1 (MCH1) receptor antagonists and uses thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4925837A (en) * 1984-09-14 1990-05-15 Synthelabo Pharmaceutical compositions

Also Published As

Publication number Publication date
KR910019618A (ko) 1991-12-19
ZA914135B (en) 1993-01-27
EP0459666A3 (en) 1992-06-03
KR930010582B1 (ko) 1993-10-30
ATE113839T1 (de) 1994-11-15
DE69105040D1 (de) 1994-12-15
MY106528A (en) 1995-06-30
PT97785B (pt) 1999-01-29
AU620282B2 (en) 1992-02-13
IE911842A1 (en) 1991-12-04
CA2043440A1 (en) 1991-12-01
DE69105040T2 (de) 1995-03-23
AU7807791A (en) 1991-12-05
HU208076B (en) 1993-08-30
EP0459666A2 (en) 1991-12-04
HU911810D0 (en) 1991-12-30
NZ238339A (en) 1997-07-27
CA2043440C (en) 1996-07-30
JPH04235917A (ja) 1992-08-25
HUT58520A (en) 1992-03-30
EP0459666B1 (en) 1994-11-09
IL98258A (en) 1996-01-31
IE63837B1 (en) 1995-06-14
DK0459666T3 (da) 1994-12-05
JP2522609B2 (ja) 1996-08-07
IL98258A0 (en) 1992-06-21

Similar Documents

Publication Publication Date Title
PT97785A (pt) Metodo para a tratamento da impotencia utilizando, por exemplo, doxazosina
DE58906926D1 (de) Neue Arzneimittelformulierung sowie Verfahren zu deren Herstellung.
DE69129800T2 (de) Behandlung von menschlichen retrovirus-infektionen mit 2',3'-dideoxyinosin
KR950002785A (ko) 골량을 증가시키기 위한 부갑상선 호르몬 및 랄옥시펜
NO922936L (no) Fremstilling av fettsyremedikamenter
DK164441C (da) Anvendelse af et piperidinderivat til fremstilling af et farmaceutisk praeparat til behandling af smertetilstande
DK0501705T3 (da) Anvendelse af tomoxetin til behandling af sygdomme i de nedre urinveje
DK0668077T3 (da) Produkter, som indeholder G-CSF og TNF-bindende protein
EP0285856A3 (en) Use of dihydroergotamine and its salts in the local treatment of trophic disorders
EP0362847A3 (en) The use of etoperidone for preparing a pharmaceutical composition for treating male impotence
ES2058451T3 (es) Un metodo para la preparacion de una composicion farmaceutica.
GR3007995T3 (pt)
DK0500953T3 (da) Potentiator af antineoplastisk virkning og antineoplastisk middel
IT1247678B (it) Metodo per la cura dell'impotenza erettiva maschile
ATE91419T1 (de) Synergistische kombination zur ophthalmischen verwendung.
IL98200A0 (en) Pharmaceutical composition containing a derivative of substituted-l-valyl-l-prolinamide
EP0260790A3 (en) Use of pinacidil in the treatment of incontinence
RU93044256A (ru) Способ лечения саркоидоза
EP0482919A3 (en) Method and composition for treating leg weakness in fowl by the administration of a non-steroidal anti-inflammatory drug
HUT43492A (en) Process for preventing and healing of gastrointestinic damages by using 3-ethoxicarbonil--1,6-dimethil-4-oxo-6,7,8,9-tetrahydro-4-h-pirido-/1,2-a/-pirimidinium-metha sulphate

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19911104

FG3A Patent granted, date of granting

Effective date: 19981009

MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 20040430